NCT07249567
Comparison of Patients With COPD and PRISM
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 20 words Show 6 more changesShow less
- Trial completed
- Final enrollment: 91 participants (planned 60)
- Primary completion date changed from estimate of Sep 5, 2026 to Mar 5, 2026
- Study completion date changed from estimate of Nov 30, 2026 to Mar 30, 2026
- Secondary endpoints: details revised at 5 of 5 entries
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Upper extremity exercise capacity
Timeframe: Baseline
Lower extremity exercise capacity
Timeframe: Baseline
Peripheral muscle strength
Timeframe: Baseline
Muscle oxygenation
Timeframe: Baseline
Respiratory Muscle Strength
Timeframe: Baseline
Respiratory Muscle Endurance
Timeframe: Baseline
Dyspnea
Timeframe: Baseline
Clinical symptoms
Timeframe: Baseline
Secondary (5)
Pulmonary function (Forced vital capacity (FVC)
Pulmonary function (Forced expiratory volume in the first second (FEV1)
Pulmonary function (FEV1 / FVC)
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%))
Pulmonary function (Peak flow rate (PEF))
Arms and interventions
Patients with COPD
Patients with chronic obstructive pulmonary disease will be included.
Patients with PRISm
Patients with preserved ratio impaired spirometry will be included.
Control
Healthy controls will be included.
Sites
1 site in 1 country
- Karabuk University, Physiotherapy and Rehabilitation Application and Research CenterKarabük, Turkey (Türkiye)